- ACC/AHA Clinical Data Standards
- acute coronary syndrome
- clinical trials
- coronary artery bypass graft
- coronary artery disease
- coronary revascularization
- percutaneous coronary intervention
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization). / Dehmer, Gregory J.; Badhwar, Vinay; Bermudez, Edmund A.; Cleveland, Joseph C.; Cohen, Mauricio G.; D'Agostino, Richard S.; Ferguson, T. Bruce; Hendel, Robert C.; Isler, Maria Lizza; Jacobs, Jeffrey P.; Jneid, Hani; Katz, Alan S.; Maddox, Thomas M.; Shahian, David M.In: Journal of the American College of Cardiology, Vol. 75, No. 16, 28.04.2020, p. 1975-2088.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - 2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization
T2 - A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization)
AU - Dehmer, Gregory J.
AU - Badhwar, Vinay
AU - Bermudez, Edmund A.
AU - Cleveland, Joseph C.
AU - Cohen, Mauricio G.
AU - D'Agostino, Richard S.
AU - Ferguson, T. Bruce
AU - Hendel, Robert C.
AU - Isler, Maria Lizza
AU - Jacobs, Jeffrey P.
AU - Jneid, Hani
AU - Katz, Alan S.
AU - Maddox, Thomas M.
AU - Shahian, David M.
N1 - Funding Information: Heart disease is the leading cause of death in the United States ( 1 ), and coronary artery disease is the most common type of heart disease ( 2 ). The annual estimated cost of heart disease in the United States is $218 billion ( 3 ). A substantial portion of this expense is related to the cost of hospitalizations for interventional cardiology and cardiac surgery ( 3 ). As healthcare costs continue to rise, increased emphasis is placed on the need to develop platforms to measure outcomes, quality, and value in medicine and surgery. Large databases, such as the Society of Thoracic Surgeons (STS) National Database, the ACC National Cardiovascular Data Registry (NCDR), and the Get With The Guidelines–Coronary Artery Disease database, contain a wealth of information on cardiac surgical procedures, invasive cardiac procedures, and selected clinical conditions but do not contain information about healthcare economics (charges and costs) and only limited data on longitudinal outcome. To address these limitations, the STS and NCDR metrics must be linked to other sources of data such as Centers for Medicare and Medicaid Services data. Such linkages of large data sets facilitate comparative effectiveness research as well as the study of longitudinal outcomes and healthcare economics, as exemplified by the ASCERT (American College of Cardiology Foundation–Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies) trial of coronary artery bypass grafting and percutaneous coronary intervention, funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health ( 4–6 ). The success of this type of research, using linked data sets, depends on the harmonization of clinical data standards and definitions across databases. The purpose of this article is to publish consensus-based key data elements and definitions for databases capturing information about coronary revascularization. Funding Information: The Task Force makes every effort to avoid actual or potential conflicts of interest that might arise because of an outside relationship or a personal, professional, or business interest of any member of the writing committee. Specifically, all members of the writing committee are required to complete and submit a disclosure form showing all such relationships that could be perceived as real or potential conflicts of interest. These statements are reviewed by the Task Force and updated when changes occur. Authors’ and peer reviewers’ relationships with industry and other entities pertinent to this data standards document are disclosed in Appendixes 1 and 2 , respectively. In addition, for complete transparency, the disclosure information of each writing committee member—including relationships not pertinent to this document—is available online as a supplement to this document. The work of the writing committee was supported exclusively by the AHA and ACC without commercial support. Writing committee members volunteered their time for this effort. Meetings of the writing committee were confidential and attended only by committee members and staff.
PY - 2020/4/28
Y1 - 2020/4/28
KW - ACC/AHA Clinical Data Standards
KW - acute coronary syndrome
KW - clinical trials
KW - coronary artery bypass graft
KW - coronary artery disease
KW - coronary revascularization
KW - percutaneous coronary intervention
UR - http://www.scopus.com/inward/record.url?scp=85083802455&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083802455&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2020.02.010
DO - 10.1016/j.jacc.2020.02.010
M3 - Article
C2 - 32202924
AN - SCOPUS:85083802455
VL - 75
SP - 1975
EP - 2088
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
SN - 0735-1097
IS - 16